313
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte–endothelial interactions

&
Pages 340-345 | Received 10 Aug 2014, Accepted 02 Nov 2014, Published online: 19 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ghulam Mohammad & Renu A Kowluru. (2022) Involvement of High Mobility Group Box 1 Protein in Optic Nerve Damage in Diabetes. Eye and Brain 14, pages 59-69.
Read now

Articles from other publishers (18)

William A. Banks, Kim M. Hansen, Michelle A. Erickson & Fulton T. Crews. (2023) High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally. Brain, Behavior, and Immunity 111, pages 386-394.
Crossref
María-Angélica Calderón-Peláez, Carolina Coronel-Ruiz, Jaime E. Castellanos & Myriam L. Velandia-Romero. (2022) Endothelial Dysfunction, HMGB1, and Dengue: An Enigma to Solve. Viruses 14:8, pages 1765.
Crossref
Emi Hibino, Natsuko Goda, Misaki Hisada, Takeshi Tenno & Hidekazu Hiroaki. (2022) Direct inhibition of the first PDZ domain of ZO-1 by glycyrrhizin is a possible mechanism of tight junction opening of Caco-2 cells. Food & Function 13:4, pages 1953-1964.
Crossref
Wenbin Yang, Stephen Chiu, Melissa Querrey, Xianpeng Liu, Qiang Wu, Emily Cerier, Mecca B. A. R. Islam, Steven J. Schwulst, G. R. Scott Budinger, Thalachallour Mohanakumar, Emilia Lecuona & Ankit Bharat. (2021) Nonclassical Monocytes Promote Edema in Lung Allografts from Traumatic Brain Injury Donors. American Journal of Respiratory Cell and Molecular Biology 64:3, pages 391-394.
Crossref
Karin Bergen, Fariborz Mobarrez, Gun Jörneskog, Håkan Wallén & Sara Tehrani. (2020) High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications. Thrombosis Research 196, pages 78-86.
Crossref
Ming Jiang, Zhuoneng Li & Guangxun Zhu. (2020) Immunological regulatory effect of flavonoid baicalin on innate immune toll-like receptors. Pharmacological Research 158, pages 104890.
Crossref
Wanlin Yang, Zihan Chang, Rongfang Que, Guomei Weng, Bin Deng, Ting Wang, Zifeng Huang, Fen Xie, Xiaobo Wei, Qin Yang, Mengyan Li, Kefu Ma, Fengli Zhou, Beisha Tang, Vincent C. T. Mok, Shuzhen Zhu & Qing Wang. (2020) Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity. Frontiers in Aging Neuroscience 12.
Crossref
Meihong Deng, Melanie J Scott, Jie Fan & Timothy R Billiar. (2019) Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. Journal of Leukocyte Biology 106:1, pages 161-169.
Crossref
Yongzhi Wang, Feifei Du, Avin Hawez, Matthias Mörgelin & Henrik Thorlacius. (2019) Neutrophil extracellular trap‐microparticle complexes trigger neutrophil recruitment via high‐mobility group protein 1 ( HMGB1 )‐toll‐like receptors( TLR2 )/ TLR4 signalling . British Journal of Pharmacology.
Crossref
Jie Weng, Lei Yu, Zhenfeng Chen, Haiying Su, Shengxiang Yu, Yuanjian Zhang, Xiaotian Lei, Lixian Chen, Yun Cui, Qiaobing Huang, Yong Jiang & Xiaohua Guo. (2019) β-Catenin phosphorylation at Y654 and Y142 is crucial for high mobility group box-1 protein-induced pulmonary vascular hyperpermeability. Journal of Molecular and Cellular Cardiology 127, pages 174-184.
Crossref
Seidu A. Richard. (2019) Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review. AIMS Neuroscience 6:4, pages 316-332.
Crossref
Aslıhan Baran, Mahmut Bulut, Mehmet Cemal Kaya, Özlem Demirpençe, Bünyamin Sevim, Eşref Akıl & Sefer Varol. (2018) High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson’s disease. Neurological Sciences 40:1, pages 167-173.
Crossref
Teresa Ravizza, Gaetano Terrone, Alessia Salamone, Federica Frigerio, Silvia Balosso, Daniel J. Antoine & Annamaria Vezzani. (2018) High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy. Brain, Behavior, and Immunity 72, pages 14-21.
Crossref
Evon S. Ereifej, Cara S. Smith, Seth M. Meade, Keying Chen, He Feng & Jeffrey R. Capadona. (2017) The Neuroinflammatory Response to Nanopatterning Parallel Grooves into the Surface Structure of Intracortical Microelectrodes. Advanced Functional Materials 28:12, pages 1704420.
Crossref
Raluca M Boteanu, Viorel I Suica, Elena Uyy, Luminita Ivan, Simona O Dima, Irinel Popescu, Maya Simionescu & Felicia Antohe. (2017) Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer. Journal of Proteomics 153, pages 21-29.
Crossref
Barry W. Festoff, Ravi K. Sajja & Luca Cucullo. (2017) Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration. BioMed Research International 2017, pages 1-14.
Crossref
Barry W. Festoff, Ravi K. Sajja, Patrick van Dreden & Luca Cucullo. (2016) HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease. Journal of Neuroinflammation 13:1.
Crossref
Philip J. Ebenezer, C. Brad Wilson, Leslie D. Wilson, Anand R. Nair & Francis J. (2016) The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD). PLOS ONE 11:9, pages e0160923.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.